Atlas Trials

Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies

Clinical trial NCT06886425 · RECRUITING

Trial details

NCT number
NCT06886425
Sponsor
Assistance Publique Hopitaux De Marseille
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Myelodysplastic Syndromes (MDS)Leukemia Acute Myeloid - AML
Start date
2021-06-14
Primary completion
2026-06-14
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.